Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Remote Ischemic Conditioning as an Adjunct Therapy for Severe COVID-19 Disease: a Prospective Randomized Pilot Study

NCT04659460 is registered in ClinicalTrials.gov with Unity Health Toronto as lead sponsor.

NCT NCT04659460
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04659460 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Remote Ischemic Conditioning as an Adjunct Therapy for Severe COVID-19 Disease: a Prospective Randomized Pilot Study
Lead sponsor
Unity Health Toronto
Phase
Not applicable
Overall status
Unknown status
Start date
December 15, 2020
Completion date
September 1, 2021
Enrollment
30 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

acute lung injury, acute respiratory distress syndrome, corona virus infection, covid, ischemia limb